EGFR and non-small cell lung carcinoma: In a retrospective study of patients with NSCLC with ≤ 3 BMs and EGFR-sensitive mutation [33], SRS + EGFR-TKIs was associated with significantly longer median OS compared to WBRT + EGFR-TKIs.